Advertisement
Advertisement

Indicator

Free Access

Pay per View

Partial Free Access

Contact Person

Dr. Elinor Switzer

Managing Editor

Phone: +49 (0)711 - 2 29 87 63
Fax: +49 (0)711 - 2 29 87 65
send an Email


Archive

Thalidomide and thrombosis - A meta-analysis

Journal: Thrombosis and Haemostasis
ISSN: 0340-6245
DOI: http://dx.doi.org/10.1160/TH06-09-0494
Issue: 2007: 97/6 (June) pp. 873-1060
Pages: 1031-1036

Thalidomide and thrombosis - A meta-analysis

Ramzi N. El Accaoui*, Wael A. Shamseddeen*, Ali T. Taher
American University of Beirut Medical Center, Beirut, Lebanon

Summary

With the increase in the number of reports and trials on the use of thalidomide as a part of the treatment of different medical conditions, particularly multiple myeloma (MM), it was observed that this drug might be associated with an increase in the risk of venous thromboembolic (VTE) events. It was the objective of this study to assess this risk, to check whether it might be affected by the concomitant administration of other medications, specifically dexamethasone, and to study the effect of anticoagulation and anti-platelet medications. A literature search for articles describing the use of thalidomide and the resultant VTE events was performed, and 50 articles were reviewed. A sample consisting of 3,322 patients resembling the above-mentioned studies was designed, and multivariate logistic regression was conducted.While thalidomide, dexamethasone and their combination were found to significantly increase the risk of VTE events among MM patients by 2.6, 2.8 and eight times, respectively,“ adequate” anticoagulation significantly reduced the risk. In conclusion, patients receiving thalidomide should be carefully monitored for thromboembolic events,and those receiving concomitantly dexamethasone or other chemotherapy should be followed even more closely. Administering prophylactic doses of low-molecular-weight heparin or warfarin with therapeutic International Normalized Ratio reduces the risk of thromboembolic events among MM patients.

Keywords

thrombosis, Multiple Myeloma, thalidomide

DOI

http://dx.doi.org/10.1160/TH06-09-0494

You may also be interested in...

1.

Frank Gieseler

Thromb Haemost 2008 99 6: 1001-1007

http://dx.doi.org/10.1160/TH08-01-0009

2.

Mohamad A. Hussein

Thromb Haemost 2006 95 6: 924-930

http://dx.doi.org/10.1160/TH06-02-0080

3.

D. Lechner; A. Weltermann

Hämostaseologie 2009 29 1: 112-120